Author

Fotini Vogiatzi

University Hospital Schleswig-Holstein

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Ammelie Svea BojeiD· 1 shared Andreas HumpeiD· 1 shared Anja LuxiD· 1 shared Anna Laqua· 1 shared Carina Lynn Gehlert· 1 shared Christian KellneriD· 1 shared Claudia Dorothea BaldusiD· 1 shared Denis Martin ScheweiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ammelie Svea BojeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A novel Fc-optimized antibody drug conjugate targeting CD7 for the therapy of T-cell acute lymphoblastic leukemia

Carina Lynn Gehlert, Denis Martin Schewe, Katja Klausz, Steffen Krohn, Dorothee Winterberg, Fotini Vogiatzi, Ammelie Svea Boje, Natalie Baum, Mona Könecke, Anja Lux, Falk Nimmerjahn, Regina Scherließ, Andreas Humpe, Martin Schrappe, Gunnar Cario, , Matthias Peipp

This paper evaluates a novel Fc-optimized antibody drug conjugate targeting CD7, showing potent anti-leukemia activity in preclinical T-ALL models.

bioRxiv · Oct 30, 2025 · PreprintCancer Biology